Anderson Woodrow D
SEC insider (Form 3/4/5 filer). CIK 0002014440. Chief Accounting Officer at Indivior Pharmaceuticals, Inc. (INDV). 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 27, 2026. Located in NORTH CHESTERFIELD, VA.
Companies Anderson Woodrow D has filed insider reports for
- Indivior Pharmaceuticals, Inc. (INDV): Officer, Chief Accounting Officer
Anderson Woodrow D
CIK: 0002014440
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Indivior Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 27, 2026INDV
Indivior Pharmaceuticals, Inc.
PurchaseDirect1.5K shares at avg. $35.69$54K - Aug 5, 2026INDV
Indivior Pharmaceuticals, Inc.
PurchaseDirect1.5K shares at avg. $36.28$54K - Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
ExerciseDirect5.9K shares- - Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
Tax PaymentDirect2.7K shares at avg. $31.98$86K - Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
ExerciseDirect18.4K shares- - Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
Tax PaymentDirect8.3K shares at avg. $31.98$265K - Feb 10, 2026INDV
Indivior Pharmaceuticals, Inc.
AwardDirect6.9K shares- - Feb 9, 2026INDV
Indivior Pharmaceuticals, Inc.
AwardDirectPerformance Stock Units
24K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 27, 2026 | INDV Indivior Pharmaceuticals, Inc. | Purchase | 1,500 | $35.69 | $53,535 | Direct |
| Aug 5, 2026 | INDV Indivior Pharmaceuticals, Inc. | Purchase | 1,500 | $36.28 | $54,420 | Direct |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | Exercise | 5,946 | - | $0 | Direct |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | Tax Payment | 2,682 | $31.98 | $85,770 | Direct |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | Exercise | 18,364 | - | $0 | Direct |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | Tax Payment | 8,283 | $31.98 | $264,890 | Direct |
| Feb 10, 2026 | INDV Indivior Pharmaceuticals, Inc. | Award | 6,903 | - | $0 | Direct |
| Feb 9, 2026 | INDV Indivior Pharmaceuticals, Inc. | Award Performance Stock Units | 23,975 | - | - | Direct |
1-8 of 8 transactions